Cancer Chemotherapy and Pharmacology addresses a wide range of pharmacologic and oncologic concerns on both experimental and clinical levels. The primary focus of this rapid publication medium is on new anticancer agents, their experimental screening, preclinical toxicology and pharmacology, single and combined drug administration modalities, and clinical phase I, II and III trials. The journal publishes results recorded in the following areas: clinical toxicology, pharmacokinetics, pharmacodynamics, drug interactions, and indications for chemotherapy in cancer treatment strategy. Cancer Chemotherapy and Pharmacology is essential reading for pharmacologists and oncologists.
Cardiovascular Toxicology is the only journal dedicated to publishing contemporary issues, timely reviews, and experimental and clinical data on the molecular therapy of cardiovascular disease. CT publishes papers that will elucidate the effects, molecular mechanisms, and signaling pathways of environmental toxicants on the cardiovascular system. Also covered are the detrimental effects of new cardiovascular drugs, and cardiovascular effects of non-cardiovascular drugs, anti-cancer chemotherapy, and gene therapy. In addition, Cardiovascular Toxicology reports safety and toxicological data on new cardiovascular and non-cardiovascular drugs. This is a unique journal in which these data can be scrutinized separately from efficacy.
Cell Biology and Toxicology is an international journal which publishes papers of high scientific standard in the areas of cell biology, genetic, molecular and cellular toxicology.The journal includes studies of subcellular and cellular systems derived from both prokaryotic and eukaryotic cell types and animal studies.The journal presents scientific reports dealing with the basic biology and with the physiological, pharmacological, and toxic response of cellular systems. Studies of toxic effects may include, but are not limited to, cytotoxicity, mutagenicity, carcinogenicity, and teratogenicity. The major focus of the journal is the mechanisms of action of toxic compounds.Cell Biology and Toxicology publishes papers describing original research results, reviews, announcements of scientific meetings or courses, and availability of funding, fellowships, and scholarships.Â
CBI discourages papers that are descriptive in nature and that do not address toxicological mechanisms (e.g., reports of toxicological effects following chemical exposure in absence of mechanistic experiments). CBI also discourages papers reporting on toxicological effects from materials, such as plant extracts or herbal medicines, that have not been chemically characterized.
Benefits to authors
We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our
Please see our
Clinical Toxicology publishes peer-reviewed scientific research and clinical advances in clinical toxicology. The journal reflects the professional concerns and best scientific judgment of its sponsors, the American Academy of Clinical Toxicology and the European Association of Poisons Centres and Clinical Toxicologists and, as such, is the leading international journal in the specialty.
Part C: Toxicology and Pharmacology is concerned with chemical and drug action at different levels of organization, biotransformation of xenobiotics, mechanisms of toxicity, including reactive oxygen species and carcinogenesis, endocrine disruptors, natural products chemistry, and signal transduction with a molecular approach to these fields.The Journal receives editorial direction from all the major societies in the field (European Society for Comparative Physiology and Biochemistry,the Japanese Society for Comparative Physiology and Biochemistry, Canadian Society of Zoologists (CBP Section), the Society for Experimental Biology, the Society for Integrative and Comparative Biology (formerly the American Society for Zoologists), the Australian and New Zealand Society for Comparative Physiology and Biochemistry, the South American Society for Comparative Physiology & Biochemistry, the Russian Physiological Society, and the Chinese Association for Physiological Sciences)Part A: Molecular & Integrative PhysiologyPart B: Biochemistry & Molecular BiologyPart D: Genomics & Proteomics
Critical Reviews in Toxicology provides up-to-date, objective analyses of topics related to the mechanisms of action, responses, and assessment of health risks due to toxicant exposure. The journal publishes critical, comprehensive reviews of research findings in toxicology and the application of toxicological information in assessing human health hazards and risks. Toxicants of concern include commodity and specialty chemicals such as formaldehyde, acrylonitrile, and pesticides; pharmaceutical agents of all types; consumer products such as macronutrients and food additives; environmental agents such as ambient ozone; and occupational exposures such as asbestos and benzene.
Current Drug Safety publishes frontier articles on all the latest advances on drug safety. The journal aims to publish the highest quality research articles, reviews and case reports in the field. Topics covered include: adverse effects of individual drugs and drug classes, management of adverse effects, pharmacovigilance and pharmacoepidemiology of new and existing drugs, post-marketing surveillance. The journal is essential reading for all researchers and clinicians involved in drug safety.
Current Nanotoxicity and Prevention aims to provide an interdisciplinary forum for researchers and practitioners, to share innovative research and engineering practices that prevent nano-toxicity.
The journal also aims to explore how innovative methods are used for detection, evaluation and mitigating nanotoxicity. In addition, new safety regulations for manufacturer/application/disposal/exposure of nanomaterials will be proposed in the journal.
DNA Repair provides a forum for the comprehensive coverage of DNA repair and cellular responses to DNA damage. The journal publishes original observations on genetic, cellular, biochemical, structural and molecular aspects of DNA repair, mutagenesis, cell cycle regulation, apoptosis and other biological responses in cells exposed to genomic insult, as well as their relationship to human disease.DNA Repair publishes full-length research articles, brief reports on research, and reviews. The journal welcomes articles describing databases, methods and new technologies supporting research on DNA repair and responses to DNA damage. Letters to the Editor, hot topics and classics in DNA repair, historical reflections, book reviews and meeting reports also will be considered for publication.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com
Dose-Response is a quarterly peer-reviewed electronic journal dedicated to the publication of original findings on the occurrence of dose-response relationships across a broad range of biological disciplines including physiology, biochemistry, molecular biology, toxicology, radiation biology, pharmacology, medicine, neuroscience, immunology, developmental biology, ecology, experimental psychology, plant biology, and environmental and related sciences. In addition to descriptive experimental findings of dose-responses, particular interest will focus on experimental evidence providing mechanistic understanding of nonlinear dose-response relationships. The journal also welcomes the submission of biologically motivated statistical modeling of dose-response relationships. While the emphasis of the journal is on the publication of experimental findings, population-based epidemiological studies relating to nonlinearity are encouraged. Dose-Response encourages the submission of mini-reviews on topics at the forefront of research interest, and the journal is particularly interested in receiving manuscripts that apply the concept of nonlinearity to current developments in drug and chemical testing procedures as well as in environmental, occupational and medical risk assessment.
Drug Safety is the official journal of the International Society of Pharmacovigilance. The journal includes: